Novavax (NVAX) Operating Income Growth (3y) (2013 - 2026)
Novavax (NVAX) Operating Income Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn | 69.02% |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - | - |
| 10 | Novavax | 1.26 Bn | 471.79 Mn | 108.82 Mn | 63.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.32% |
| Dec 31, 2025 | 27.21% |
| Sep 30, 2025 | -11.86% |
| Jun 30, 2025 | 30.24% |
| Mar 31, 2025 | 35.05% |
| Dec 31, 2024 | 45.84% |
| Sep 30, 2024 | 24.15% |
| Jun 30, 2024 | 35.09% |
| Mar 31, 2024 | 11.46% |
| Dec 31, 2023 | -0.13% |
| Sep 30, 2023 | 13.47% |
| Jun 30, 2023 | 73.88% |
| Mar 31, 2023 | -139.05% |
| Dec 31, 2022 | -104.05% |
| Sep 30, 2022 | -103.98% |
| Jun 30, 2022 | -136.17% |
| Mar 31, 2022 | 93.13% |
| Dec 31, 2021 | -160.79% |
| Sep 30, 2021 | -94.26% |
| Jun 30, 2021 | -101.94% |